World's Best Scientists 2026 revealed!
Annals of Hematology
H-index 30

Annals of Hematology

0939-5555

Published by: Springer

https://www.springer.com/journal/277

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 166 34 47 10
Medicine 703 316 475 28

Additional Metrics

Number of Best Scientists*: 488
Documents by Best Scientists*: 639
Top 100 Ranked Scientists*: 7
SCIMAGO H-index: 95
SCIMAGO SJR: 0.862
Impact Factor: 2.4

Overview

Top Research Topics at Annals of Hematology?

The concepts of Internal medicine, Hematology, Immunology, Gastroenterology and Pathology are tackled in the journal. Surgery and Oncology are some topics wherein Internal medicine research discussed in it have an impact. More specifically, the research on Surgery in Annals of Hematology is related to Regimen.

Annals of Hematology addresses concerns in Hematology which are intertwined with other disciplines, such as Cancer research, Myeloid leukemia, Transplantation, Lymphoma and Multiple myeloma. It centers on topics in Transplantation, with a focus on Hematopoietic stem cell transplantation. Immunology research discussed connects with the study of Haematopoiesis.

The study on Gastroenterology presented in it intersects with subjects under the field of Anemia. Annals of Hematology features Leukemia research that overlaps with concepts in Myeloid.

  • Internal medicine (67.60%)
  • Hematology (52.84%)
  • Immunology (20.94%)

What are the most cited papers published in the journal?

  • The IgG Fc receptor family (434 citations)
  • Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology (392 citations)
  • Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia (343 citations)

Research areas of the most cited articles at Annals of Hematology:

The most cited publications aim to foster the development of research in Internal medicine, Hematology, Immunology, Surgery and Gastroenterology. The studies on Internal medicine discussed at the published articles can also contribute to research in the domains of Oncology and Pathology. The journal articles explore topics in Hematology which can be helpful for research in disciplines like Transplantation, Myeloid leukemia, Myelodysplastic syndromes, Bone marrow and Multiple myeloma.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

Annals of Hematology primarily tackles Internal medicine, Hematology, Oncology, Gastroenterology and Transplantation. Annals of Hematology tackles issues in Internal medicine, particularly in the topics of Multiple myeloma, Myeloid leukemia, Hematopoietic stem cell transplantation, Cohort and Retrospective cohort study. Research in the field of Immunology was used to conduct the presented Hematology study.

Annals of Hematology explores issues in Oncology which can be linked to other research areas like Venetoclax and MEDLINE. The studies on Gastroenterology discussed can also contribute to research in the domains of Regimen, Adverse effect, Cumulative incidence and Lymphoma. The studies in Transplantation featured incorporate elements of Cyclophosphamide and Stem cell.

The most cited articles from the last journal are:

  • COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry (31 citations)
  • Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection. (17 citations)
  • Hematologic disorders associated with COVID-19: a review. (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Annals of Hematology (based on the number of publications) are:

  • Yok-Lam Kwong (68 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • Arnold Ganser (61 papers) absent at the last edition,
  • Klaus Lechner (58 papers) absent at the last edition,
  • Mineo Kurokawa (50 papers) published 6 papers at the last edition,
  • Xiao-Jun Huang (43 papers) published 7 papers at the last edition, 1 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Annals of Hematology (based on the number of publications) are:

  • Ludwig Maximilian University of Munich (243 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • University of Ulm (187 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Heidelberg University (151 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • University of Vienna (137 papers) absent at the last edition,
  • Boston Children's Hospital (133 papers) published 8 papers at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 8.35% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.07% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.19% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.00% of all publications and 66.75% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes

    (2022)
    106 Citations
  • Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry

    Hubert Schrezenmeier;Hubert Schrezenmeier;Alexander Röth;David J Araten;Yuzuru Kanakura

    (2020)
    101 Citations
  • Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19

    (2020)
    84 Citations
  • Management of myelofibrosis after ruxolitinib failure

    Claire N Harrison;Nicolaas Schaap;Ruben A Mesa

    (2020)
    82 Citations
  • Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes

    (2022)
    63 Citations
  • Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

    Annika Y. Classen;Larissa Henze;Marie von Lilienfeld-Toal;Georg Maschmeyer

    (2021)
    60 Citations
  • Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review

    (2021)
    49 Citations
  • Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

    Maximilian Christopeit;Martin Schmidt-Hieber;Rosanne Sprute;Dieter Buchheidt

    (2021)
    49 Citations
  • Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.

    Toshihiro Matsukawa;Keito Suto;Minoru Kanaya;Koh Izumiyama

    (2020)
    42 Citations

Related Online Degrees & Career Pathways

For those exploring medical careers beyond traditional medical school routes, there are a variety of related online degrees and career pathways to consider. Registered nurses looking to advance their education can benefit from the cheapest bsn to msn online programs, which offer an affordable way to obtain a master's degree and open doors to leadership and specialized roles.

If clinical practicums are a concern, some programs provide flexibility. The rn to bsn no practicum paths allow nurses to gain their bachelor's degree entirely online without the need for traditional clinical hours, making it ideal for working professionals.

For advanced practice nurses aiming for leadership or specialized clinical roles, accelerated dnp programs online offer streamlined pathways to doctoral education. These programs focus on enhancing clinical expertise and improving healthcare outcomes through evidence-based practice.

Additionally, those interested in quickly entering the healthcare field might consider becoming a medical assistant. There are excellent medical assistant programs accelerated options that can prepare students for certification in as little as six weeks, providing a fast track to employment in various medical settings.

Best Scientists Contributing to This Journal

Recently Published Articles